WPP to take control of Turkish agency
WPP, the media and advertising giant led by frontman Sir Martin Sorrell, wants to buy up the remaining stake in Turkish agency Manajans Thompson Reklam Isleri.
WPP, the media and advertising giant led by frontman Sir Martin Sorrell, wants to buy up the remaining stake in Turkish agency Manajans Thompson Reklam Isleri.
The acquisition, subject to regulatory approval, will see WPP increase its current minority interest - held since 1985 - to 100% following completion. The purchase will be made through WPP's wholly-owned marketing communications division JWT.
Manajans, founded in 1944, is based in Istanbul and employs around 70 people. Its clients include Bayer, Nokia, Shell, Turkcell and Ulker. It generated 8.0m Turkish lira (£2.85m) in revenues in 2011.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
WPP said: "This investment continues WPP's strategy of investing in fast growing markets and sectors, such as the Next 11 (which includes Turkey) where WPP employs 10,000 people and generates revenues (including associates) of around $800m."
The group already employs nearly 1,000 people in Turkey, where it generates annual sales of around $100m.
BC
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published